Jingtao Chen
Papers
3
Total Citations
25
H-Index
3
About
Dr. Jingtao Chen is a pioneering researcher at the intersection of surgical robotics and oncology, whose work spans the design of advanced multi-degree-of-freedom robotic systems and the clinical translation of immunochemotherapy combined with transoral robotic surgery (TORS). His most cited paper (18 citations) introduces a novel surgical robotic system for brachytherapy on liver tumors, addressing critical challenges in accuracy and radiation exposure during radioactive seed implantation for hepatocellular carcinomas. Dr. Chen has made landmark contributions to oropharyngeal cancer (OPC) treatment, leading a phase 2 trial (2025) demonstrating that neoadjuvant sintilimab and chemotherapy followed by TORS yields major pathological responses in HPV-positive resectable OPC—a paradigm-shifting approach that reduces surgical morbidity while leveraging immunotherapy. His 2024 study further elucidates how HPV infection impacts OPC prognosis, providing evidence for tailored robotic surgical strategies. With cumulative citations exceeding 25, Dr. Chen’s work bridges engineering innovation and clinical practice, offering safer, more effective interventions for liver and head-and-neck cancers. His achievements underscore a commitment to translating robotic precision into tangible patient outcomes, making him a key figure in the evolution of minimally invasive oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3